RaaS Group
@raasgroup
RaaS (Research as a Service) is a Sydney, Australia-based, independent research house focused on closing the price/valuation gap for small/ micro cap companies.
ID: 950498343809032192
http://www.raasgroup.com 08-01-2018 22:43:59
202 Tweet
179 Takipçi
493 Takip Edilen
@RaaSGroup will focus on Gold at its next Stock Take Webinar on Wednesday November 19 at 12pm AEDT. Get Joshua Baker's take on the sector and then hear from $HRZ, $STN and $SHN followed by live Q&A. Register your spot here: us02web.zoom.us/webinar/regist… 1 CPD point available for attendance.
RaaS Group has initiated coverage of antiviral therapeutics company islandpharmaceuticals $ILA with a probability-weighted NPV of $0.76/share, which represents 58% potential capital upside to the current price. Our full report is available at raasgroup.com/live/ - join our mailing
RaaS Group has published a new RaaS+ report for subscribers on place-based media company Motio $MXO. $MXO has delivered 30% year-on-year growth over the past two financial years, is cash-flow positive, NPAT positive and well-funded, in our view, to continue its rollout of
RaaS Group has published an update on energy transportation solutions company Provaris Energy $PV1. No change to our valuation. Our full report is available at raasgroup.com/live/ #energy #transportation
RaaS Group has published an update on junior gold producer Horizon Minerals $HRZ following its divestment of the Lake Johnston project. Our valuation is now $0.0246/share. All our HRZ research is available to download at raasgroup.com/live/ #gold #asxgoldstocks
Don't miss the RaaS Group Gold Stock Take Webinar tomorrow (Wed 19th) at 12pm AEDT in which Joshua Baker gives his take on the sector followed by presentations from Horizon Minerals $HRZ, Saturn Metals $STN and Aureka $AKA. Book your spot here us02web.zoom.us/webinar/regist…
RaaS Group has published an update on antiviral therapeutics company islandpharmaceuticals $ILA following positive FDA feedback on its Galidesivir programme for Marburg. We have increased our probability weighted NPV to $1.14/share from $0.76/share representing 115% potential capital
RaaS Group has just published an interview with Cash Converters $CCV CEO/MD Sam Budiselik conducted by our senior analyst Graeme Carson. The full 13:44min interview is available at our YouTube channel. youtu.be/k_9YqSMu8EE
RaaS Group has published the full transcript of our 13:44min interview with Cash Converters $CCV CEO/MD Sam Budiselik. Full document can be downloaded at raasgroup.com/live/
If you missed our RaaS Stock Take Webinar on Gold yesterday, the good news is we have a recording! Click to view on our YouTube channel: youtube.com/live/xhsNfXB-q… #gold #asxgoldstocks Joshua Baker
RaaS Group has just published a new report on WA emerging gold producer Horizon Minerals $HRZ. The ful report can be downloaded at raasgroup.com/live/ #gold #goldproducer #asxgoldstocks
RaaS Group has publihed a new report on islandpharmaceuticals $ILA which can be downloaded at raasgroup.com/live/ #biotech #pharma #lifesciences
A big congratulations to RaaS Group Senior Analyst John Burgess for his well-timed call on Temple & Webster $TPW. Back in June we published a five-page report to RaaS+ subscribers calling out what had been priced into TPW's share price at $22.60. Yesterday TPW closed 62% lower.